

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89668142 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.66775167 |
| 3 | nuclear pore organization (GO:0006999) | 4.09445655 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.07770799 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.07770799 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02237366 |
| 7 | pore complex assembly (GO:0046931) | 3.69071625 |
| 8 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.63598577 |
| 9 | mitotic sister chromatid cohesion (GO:0007064) | 3.57885281 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52381287 |
| 11 | positive regulation of histone deacetylation (GO:0031065) | 3.46786203 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44295629 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.36188784 |
| 14 | tolerance induction (GO:0002507) | 3.35900109 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 3.30916096 |
| 16 | response to peptidoglycan (GO:0032494) | 3.27818201 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 3.19490885 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 3.16658616 |
| 19 | histamine secretion (GO:0001821) | 3.12204994 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.10689497 |
| 21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10428238 |
| 22 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.10020391 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.08117573 |
| 24 | negative T cell selection (GO:0043383) | 3.06994665 |
| 25 | dosage compensation (GO:0007549) | 3.06726506 |
| 26 | B cell receptor signaling pathway (GO:0050853) | 3.06132459 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.03780009 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01608191 |
| 29 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.01497437 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 2.99832966 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 2.99832966 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99720751 |
| 33 | histone H3-K9 demethylation (GO:0033169) | 2.99064806 |
| 34 | corticosteroid receptor signaling pathway (GO:0031958) | 2.98384677 |
| 35 | regulation of RNA export from nucleus (GO:0046831) | 2.96320148 |
| 36 | embryonic hemopoiesis (GO:0035162) | 2.93468578 |
| 37 | histone H3-K4 trimethylation (GO:0080182) | 2.91301350 |
| 38 | negative regulation of B cell proliferation (GO:0030889) | 2.90032673 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86288618 |
| 40 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85047547 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 2.84676073 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84027581 |
| 43 | B cell proliferation (GO:0042100) | 2.82592866 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 2.81869734 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81236985 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 2.79981837 |
| 47 | hypotonic response (GO:0006971) | 2.78105338 |
| 48 | positive T cell selection (GO:0043368) | 2.77171878 |
| 49 | thymic T cell selection (GO:0045061) | 2.76019380 |
| 50 | T cell selection (GO:0045058) | 2.74984287 |
| 51 | stress fiber assembly (GO:0043149) | 2.74383428 |
| 52 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.73233581 |
| 53 | embryonic process involved in female pregnancy (GO:0060136) | 2.72854110 |
| 54 | response to interleukin-15 (GO:0070672) | 2.68759921 |
| 55 | growth hormone receptor signaling pathway (GO:0060396) | 2.68588927 |
| 56 | regulation of histone deacetylation (GO:0031063) | 2.68341539 |
| 57 | megakaryocyte development (GO:0035855) | 2.67942750 |
| 58 | positive regulation of granulocyte differentiation (GO:0030854) | 2.66429328 |
| 59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63688663 |
| 60 | T cell costimulation (GO:0031295) | 2.62494642 |
| 61 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61959354 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 2.61652650 |
| 63 | erythrocyte maturation (GO:0043249) | 2.61015385 |
| 64 | regulation of establishment of cell polarity (GO:2000114) | 2.60425327 |
| 65 | lymphocyte costimulation (GO:0031294) | 2.59855959 |
| 66 | leukocyte tethering or rolling (GO:0050901) | 2.58492880 |
| 67 | detection of external biotic stimulus (GO:0098581) | 2.58305208 |
| 68 | histone H3-K4 methylation (GO:0051568) | 2.58220763 |
| 69 | regulation of DNA endoreduplication (GO:0032875) | 2.58198781 |
| 70 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.57379271 |
| 71 | * hepatocyte apoptotic process (GO:0097284) | 2.56810992 |
| 72 | leukocyte aggregation (GO:0070486) | 2.56694959 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56501158 |
| 74 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56501158 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56501158 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 2.56501158 |
| 77 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56501158 |
| 78 | modulation by symbiont of host defense response (GO:0052031) | 2.56501158 |
| 79 | positive regulation of leukocyte degranulation (GO:0043302) | 2.55530202 |
| 80 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.55362510 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 2.53926958 |
| 82 | B cell homeostasis (GO:0001782) | 2.53716618 |
| 83 | regulation of B cell differentiation (GO:0045577) | 2.53109887 |
| 84 | detection of other organism (GO:0098543) | 2.51947013 |
| 85 | cell adhesion mediated by integrin (GO:0033627) | 2.51879592 |
| 86 | cellular response to ethanol (GO:0071361) | 2.51781332 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 2.51269287 |
| 88 | regulation of granulocyte differentiation (GO:0030852) | 2.49761481 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49608998 |
| 90 | negative regulation of necroptotic process (GO:0060546) | 2.47927624 |
| 91 | cellular response to interleukin-15 (GO:0071350) | 2.47847377 |
| 92 | germ cell migration (GO:0008354) | 2.47814238 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46706566 |
| 94 | germinal center formation (GO:0002467) | 2.46224533 |
| 95 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.45823825 |
| 96 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.45442383 |
| 97 | glycolipid catabolic process (GO:0019377) | 2.45154045 |
| 98 | coronary vasculature morphogenesis (GO:0060977) | 2.44407838 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 2.44148847 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.43194115 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42996587 |
| 102 | regulation of macrophage cytokine production (GO:0010935) | 2.42883670 |
| 103 | pinocytosis (GO:0006907) | 2.42824268 |
| 104 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.42513160 |
| 105 | mitotic chromosome condensation (GO:0007076) | 2.41857238 |
| 106 | regulation of ARF protein signal transduction (GO:0032012) | 2.41612300 |
| 107 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.41264409 |
| 108 | regulation of B cell proliferation (GO:0030888) | 2.39879006 |
| 109 | T cell migration (GO:0072678) | 2.39616610 |
| 110 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38236331 |
| 111 | response to thyroid hormone (GO:0097066) | 2.37467930 |
| 112 | oligosaccharide catabolic process (GO:0009313) | 2.37117057 |
| 113 | regulation of necroptotic process (GO:0060544) | 2.36585944 |
| 114 | peptidyl-lysine trimethylation (GO:0018023) | 2.35638486 |
| 115 | positive regulation of protein deacetylation (GO:0090312) | 2.35281597 |
| 116 | myeloid cell development (GO:0061515) | 2.34872726 |
| 117 | DNA topological change (GO:0006265) | 2.34785729 |
| 118 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.34251609 |
| 119 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.34208191 |
| 120 | histone H3-K36 demethylation (GO:0070544) | 2.34168222 |
| 121 | positive regulation of chemokine secretion (GO:0090197) | 2.34044927 |
| 122 | definitive hemopoiesis (GO:0060216) | 2.33770674 |
| 123 | barbed-end actin filament capping (GO:0051016) | 2.33323284 |
| 124 | regulation of protein deacetylation (GO:0090311) | 2.32820465 |
| 125 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.32210827 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.29717025 |
| 127 | negative regulation of stress fiber assembly (GO:0051497) | 2.29485927 |
| 128 | positive regulation of macrophage cytokine production (GO:0060907) | 2.28659835 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.28508774 |
| 130 | interferon-gamma production (GO:0032609) | 2.27680696 |
| 131 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.27676149 |
| 132 | cellular hyperosmotic response (GO:0071474) | 2.27147445 |
| 133 | negative regulation of anoikis (GO:2000811) | 2.27097596 |
| 134 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.27039683 |
| 135 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.27039683 |
| 136 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.26674268 |
| 137 | peptidyl-threonine phosphorylation (GO:0018107) | 2.26251165 |
| 138 | neutrophil activation (GO:0042119) | 2.25881873 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.25795161 |
| 140 | histamine transport (GO:0051608) | 2.25582268 |
| 141 | toll-like receptor signaling pathway (GO:0002224) | 2.25479780 |
| 142 | nerve growth factor signaling pathway (GO:0038180) | 2.24299287 |
| 143 | mature B cell differentiation (GO:0002335) | 2.24033836 |
| 144 | response to host (GO:0075136) | 2.23425706 |
| 145 | response to host defenses (GO:0052200) | 2.23425706 |
| 146 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.23425706 |
| 147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.22299628 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.22027641 |
| 149 | positive regulation of lamellipodium assembly (GO:0010592) | 2.21913440 |
| 150 | peptidyl-threonine modification (GO:0018210) | 2.21580338 |
| 151 | osteoclast differentiation (GO:0030316) | 2.21573516 |
| 152 | necroptotic process (GO:0070266) | 2.21140898 |
| 153 | cellular response to arsenic-containing substance (GO:0071243) | 2.21096325 |
| 154 | protein localization to endosome (GO:0036010) | 2.20961272 |
| 155 | cellular response to growth hormone stimulus (GO:0071378) | 2.20601261 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.20579659 |
| 157 | response to host immune response (GO:0052572) | 2.20579659 |
| 158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.20514171 |
| 159 | V(D)J recombination (GO:0033151) | 2.19239203 |
| 160 | MyD88-dependent toll-like receptor signaling pathway (GO:0002755) | 2.17326463 |
| 161 | COPII vesicle coating (GO:0048208) | 2.16832916 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.16415751 |
| 163 | cortical actin cytoskeleton organization (GO:0030866) | 2.16278347 |
| 164 | membrane raft organization (GO:0031579) | 2.15322987 |
| 165 | natural killer cell differentiation (GO:0001779) | 2.14954866 |
| 166 | T cell homeostasis (GO:0043029) | 2.14794429 |
| 167 | positive regulation of p38MAPK cascade (GO:1900745) | 2.14354264 |
| 168 | activated T cell proliferation (GO:0050798) | 2.14273462 |
| 169 | negative regulation of histone methylation (GO:0031061) | 2.14228465 |
| 170 | I-kappaB phosphorylation (GO:0007252) | 2.13800157 |
| 171 | positive regulation of lamellipodium organization (GO:1902745) | 2.13638180 |
| 172 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.13482172 |
| 173 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.13482172 |
| 174 | detection of biotic stimulus (GO:0009595) | 2.12927439 |
| 175 | T cell receptor signaling pathway (GO:0050852) | 2.11023180 |
| 176 | cellular extravasation (GO:0045123) | 2.10992034 |
| 177 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.10060161 |
| 178 | Notch signaling involved in heart development (GO:0061314) | 2.09993551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.70832775 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.35852611 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.59700191 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25692474 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.02709310 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79165642 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74874832 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.72494171 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67286828 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.60598878 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59451538 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56427594 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48278909 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39717511 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35699248 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33829714 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30438278 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08507805 |
| 19 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.99083205 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98665904 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.96175980 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89416230 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87972252 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.85732826 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84934314 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82871411 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82729447 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.81492360 |
| 29 | GATA1_19941826_ChIP-Seq_K562_Human | 1.81319484 |
| 30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.79010192 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.75958674 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.75051524 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74498650 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74265266 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73096162 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.72351145 |
| 37 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.72113355 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71373119 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.70255965 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69791992 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66987262 |
| 42 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63825845 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63283603 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62469565 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60699523 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58309823 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55407224 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53997840 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.53853993 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53501688 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52327360 |
| 52 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51201282 |
| 53 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50650210 |
| 54 | GATA2_19941826_ChIP-Seq_K562_Human | 1.46683983 |
| 55 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44758098 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42712064 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40730232 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40292681 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38404128 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37173621 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36068082 |
| 62 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35990908 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.34397149 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34239452 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34063599 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33217551 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31788046 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30942865 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30574822 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30402194 |
| 71 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.29983200 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27740294 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26405217 |
| 74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.25343888 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24920359 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24574114 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23690166 |
| 78 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20185334 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20134103 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20134103 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19046791 |
| 82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18655664 |
| 83 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17436211 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16926451 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16601544 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16335302 |
| 87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16317331 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.14780489 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12321919 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10249470 |
| 91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09003936 |
| 92 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.08104414 |
| 93 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.07877977 |
| 94 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.07077920 |
| 95 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.05749359 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03786939 |
| 97 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.02229370 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01331937 |
| 99 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01234339 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99658425 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99023999 |
| 102 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.97858094 |
| 103 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97495924 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95672617 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94771610 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92581026 |
| 107 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92124409 |
| 108 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92106358 |
| 109 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91898175 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91455992 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90749427 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90322907 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88562439 |
| 114 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87955200 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87861315 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86510698 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86503526 |
| 118 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86347901 |
| 119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86263964 |
| 120 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85330241 |
| 121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85242746 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84752040 |
| 123 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84260952 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 0.84119234 |
| 125 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83642453 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83561163 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83496117 |
| 128 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82237178 |
| 129 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81049704 |
| 130 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80529610 |
| 131 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79753872 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78871260 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78759797 |
| 134 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78065808 |
| 135 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77790712 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77783858 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77695788 |
| 138 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76886518 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76502213 |
| 140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76400456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.51055567 |
| 2 | * MP0003300_gastrointestinal_ulcer | 3.08748167 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.81749397 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.67474399 |
| 5 | MP0005671_abnormal_response_to | 2.67473934 |
| 6 | * MP0002166_altered_tumor_susceptibility | 2.57687279 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.51334394 |
| 8 | MP0000685_abnormal_immune_system | 2.46541657 |
| 9 | MP0001800_abnormal_humoral_immune | 2.40832591 |
| 10 | MP0005387_immune_system_phenotype | 2.37226226 |
| 11 | MP0001790_abnormal_immune_system | 2.37226226 |
| 12 | MP0003303_peritoneal_inflammation | 2.29972756 |
| 13 | MP0004147_increased_porphyrin_level | 2.16648596 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.12071140 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.10891980 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.08082668 |
| 17 | * MP0002006_tumorigenesis | 2.04484759 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.04076496 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.03397686 |
| 20 | * MP0002877_abnormal_melanocyte_morpholog | 1.99933723 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.99042320 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.97514229 |
| 23 | MP0001819_abnormal_immune_cell | 1.96431508 |
| 24 | MP0005451_abnormal_body_composition | 1.95571124 |
| 25 | MP0005310_abnormal_salivary_gland | 1.91731571 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.90385133 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.89525470 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.88706938 |
| 29 | MP0002723_abnormal_immune_serum | 1.87140266 |
| 30 | MP0001873_stomach_inflammation | 1.87108839 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.83666116 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.82843505 |
| 33 | MP0004510_myositis | 1.79236913 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.78907103 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.72913957 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.71865419 |
| 37 | * MP0000716_abnormal_immune_system | 1.71189333 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.70938148 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.69158288 |
| 40 | MP0002405_respiratory_system_inflammati | 1.68595762 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.64907432 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.64907432 |
| 43 | MP0010307_abnormal_tumor_latency | 1.63471304 |
| 44 | * MP0002009_preneoplasia | 1.61905899 |
| 45 | MP0001851_eye_inflammation | 1.59936890 |
| 46 | MP0003436_decreased_susceptibility_to | 1.59600149 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.54336924 |
| 48 | MP0002419_abnormal_innate_immunity | 1.53905888 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.51939861 |
| 50 | MP0003866_abnormal_defecation | 1.50693401 |
| 51 | MP0002722_abnormal_immune_system | 1.50173692 |
| 52 | MP0002254_reproductive_system_inflammat | 1.48834372 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.48266121 |
| 54 | MP0005025_abnormal_response_to | 1.43838086 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.43738218 |
| 56 | MP0004947_skin_inflammation | 1.42105027 |
| 57 | MP0003045_fibrosis | 1.42098275 |
| 58 | * MP0002429_abnormal_blood_cell | 1.40675108 |
| 59 | MP0009278_abnormal_bone_marrow | 1.36980352 |
| 60 | * MP0010094_abnormal_chromosome_stability | 1.36789269 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.30650280 |
| 62 | MP0008260_abnormal_autophagy | 1.28779589 |
| 63 | MP0001915_intracranial_hemorrhage | 1.25207843 |
| 64 | MP0003091_abnormal_cell_migration | 1.24330405 |
| 65 | * MP0000733_abnormal_muscle_development | 1.24042231 |
| 66 | MP0000490_abnormal_crypts_of | 1.19893224 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 1.18120600 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.17822980 |
| 69 | MP0009785_altered_susceptibility_to | 1.15576863 |
| 70 | MP0008961_abnormal_basal_metabolism | 1.14922004 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.14107794 |
| 72 | * MP0003448_altered_tumor_morphology | 1.12931249 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.10856757 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.09556526 |
| 75 | MP0000371_diluted_coat_color | 1.08505200 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 1.05901609 |
| 77 | MP0004130_abnormal_muscle_cell | 1.04085186 |
| 78 | * MP0003111_abnormal_nucleus_morphology | 1.03783519 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.03362706 |
| 80 | MP0009115_abnormal_fat_cell | 1.02390135 |
| 81 | MP0005171_absent_coat_pigmentation | 1.02284677 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.01700269 |
| 83 | * MP0003787_abnormal_imprinting | 1.01366008 |
| 84 | MP0009840_abnormal_foam_cell | 0.98901787 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.97848525 |
| 86 | MP0002971_abnormal_brown_adipose | 0.97317028 |
| 87 | MP0001853_heart_inflammation | 0.96622616 |
| 88 | MP0000383_abnormal_hair_follicle | 0.96489303 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.94124288 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.93455117 |
| 91 | MP0009697_abnormal_copulation | 0.93430029 |
| 92 | MP0008057_abnormal_DNA_replication | 0.92866146 |
| 93 | MP0003724_increased_susceptibility_to | 0.92678818 |
| 94 | MP0003828_pulmonary_edema | 0.92003123 |
| 95 | MP0001730_embryonic_growth_arrest | 0.91437281 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.90873722 |
| 97 | MP0006054_spinal_hemorrhage | 0.90122818 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.89840283 |
| 99 | MP0002933_joint_inflammation | 0.87598018 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.86272306 |
| 101 | MP0000747_muscle_weakness | 0.85951629 |
| 102 | MP0002060_abnormal_skin_morphology | 0.85494241 |
| 103 | MP0006082_CNS_inflammation | 0.84806165 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.83324829 |
| 105 | MP0004233_abnormal_muscle_weight | 0.82355684 |
| 106 | * MP0002019_abnormal_tumor_incidence | 0.80924544 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.79317642 |
| 108 | MP0002928_abnormal_bile_duct | 0.78786902 |
| 109 | MP0003950_abnormal_plasma_membrane | 0.78527010 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.77878369 |
| 111 | * MP0005384_cellular_phenotype | 0.77588328 |
| 112 | MP0000249_abnormal_blood_vessel | 0.77179433 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.76984971 |
| 114 | MP0004883_abnormal_blood_vessel | 0.76902700 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.76643597 |
| 116 | MP0004957_abnormal_blastocyst_morpholog | 0.75483849 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.74124272 |
| 118 | MP0003690_abnormal_glial_cell | 0.72337556 |
| 119 | * MP0000858_altered_metastatic_potential | 0.72324754 |
| 120 | MP0000343_altered_response_to | 0.69565372 |
| 121 | MP0005621_abnormal_cell_physiology | 0.67556192 |
| 122 | MP0003077_abnormal_cell_cycle | 0.66226417 |
| 123 | MP0005334_abnormal_fat_pad | 0.64388334 |
| 124 | MP0004885_abnormal_endolymph | 0.62916075 |
| 125 | MP0000377_abnormal_hair_follicle | 0.61318095 |
| 126 | MP0005670_abnormal_white_adipose | 0.60270331 |
| 127 | MP0005409_darkened_coat_color | 0.60144538 |
| 128 | MP0008569_lethality_at_weaning | 0.59995301 |
| 129 | MP0002098_abnormal_vibrissa_morphology | 0.58107100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.10759449 |
| 2 | Papilledema (HP:0001085) | 3.60458945 |
| 3 | Thyroiditis (HP:0100646) | 3.55053717 |
| 4 | Volvulus (HP:0002580) | 3.51158071 |
| 5 | B lymphocytopenia (HP:0010976) | 3.49250131 |
| 6 | Abnormality of B cell number (HP:0010975) | 3.49250131 |
| 7 | Recurrent viral infections (HP:0004429) | 3.39319424 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24421183 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24421183 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24421183 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.12845822 |
| 12 | T lymphocytopenia (HP:0005403) | 2.95780816 |
| 13 | Agammaglobulinemia (HP:0004432) | 2.95634439 |
| 14 | Poikilocytosis (HP:0004447) | 2.92406893 |
| 15 | Recurrent abscess formation (HP:0002722) | 2.89777050 |
| 16 | Abnormality of T cell number (HP:0011839) | 2.83918463 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 2.80242263 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 2.77333240 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.76376855 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 2.73135962 |
| 21 | Optic neuritis (HP:0100653) | 2.73135962 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 2.70226573 |
| 23 | IgM deficiency (HP:0002850) | 2.69498110 |
| 24 | Cellulitis (HP:0100658) | 2.65636347 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62371875 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.62371875 |
| 27 | Myositis (HP:0100614) | 2.62324750 |
| 28 | Viral hepatitis (HP:0006562) | 2.59050993 |
| 29 | Termporal pattern (HP:0011008) | 2.58731684 |
| 30 | Insidious onset (HP:0003587) | 2.58731684 |
| 31 | Acanthocytosis (HP:0001927) | 2.56327566 |
| 32 | Orthostatic hypotension (HP:0001278) | 2.53869243 |
| 33 | Eosinophilia (HP:0001880) | 2.53020948 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.51909827 |
| 35 | Orchitis (HP:0100796) | 2.51890890 |
| 36 | Hematochezia (HP:0002573) | 2.51208781 |
| 37 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.43446497 |
| 38 | Subacute progressive viral hepatitis (HP:0006572) | 2.43201096 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.41354640 |
| 40 | Combined immunodeficiency (HP:0005387) | 2.41112189 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.41003371 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39920943 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39920943 |
| 44 | Macroorchidism (HP:0000053) | 2.39146357 |
| 45 | Spondylolisthesis (HP:0003302) | 2.38716851 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.37996303 |
| 47 | Colitis (HP:0002583) | 2.36315023 |
| 48 | Vasculitis (HP:0002633) | 2.34918916 |
| 49 | Gastrointestinal stroma tumor (HP:0100723) | 2.34915078 |
| 50 | Papilloma (HP:0012740) | 2.33273039 |
| 51 | Verrucae (HP:0200043) | 2.33273039 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.33205163 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.33129490 |
| 54 | Disinhibition (HP:0000734) | 2.32841246 |
| 55 | Meningitis (HP:0001287) | 2.31150975 |
| 56 | Aortic aneurysm (HP:0004942) | 2.28968941 |
| 57 | Narrow palate (HP:0000189) | 2.27617081 |
| 58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24069746 |
| 59 | Fatigue (HP:0012378) | 2.21587883 |
| 60 | Spinal cord lesions (HP:0100561) | 2.21502221 |
| 61 | Syringomyelia (HP:0003396) | 2.21502221 |
| 62 | Loss of speech (HP:0002371) | 2.18463624 |
| 63 | Ankyloglossia (HP:0010296) | 2.18109275 |
| 64 | Leukocytosis (HP:0001974) | 2.16418445 |
| 65 | Lip pit (HP:0100267) | 2.15287057 |
| 66 | Chronic diarrhea (HP:0002028) | 2.11922036 |
| 67 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.11229189 |
| 68 | Truncal obesity (HP:0001956) | 2.10553000 |
| 69 | Granulocytopenia (HP:0001913) | 2.10453766 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.10122342 |
| 71 | Absent frontal sinuses (HP:0002688) | 2.09745657 |
| 72 | * Transitional cell carcinoma of the bladder (HP:0006740) | 2.09169917 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.07918296 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.03871252 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.03793667 |
| 76 | Lymphopenia (HP:0001888) | 2.02840944 |
| 77 | Subaortic stenosis (HP:0001682) | 2.02272242 |
| 78 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.02272242 |
| 79 | IgA deficiency (HP:0002720) | 2.02094833 |
| 80 | Osteomyelitis (HP:0002754) | 2.01160403 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.01095032 |
| 82 | Deep philtrum (HP:0002002) | 2.01008023 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.00909860 |
| 84 | Acute myeloid leukemia (HP:0004808) | 1.99835020 |
| 85 | Amelogenesis imperfecta (HP:0000705) | 1.99000312 |
| 86 | Abnormality of oral frenula (HP:0000190) | 1.97773429 |
| 87 | Prolonged bleeding time (HP:0003010) | 1.91743468 |
| 88 | Autoamputation (HP:0001218) | 1.91715539 |
| 89 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.91375110 |
| 90 | Conjunctival telangiectasia (HP:0000524) | 1.91317398 |
| 91 | Pustule (HP:0200039) | 1.90411561 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90408710 |
| 93 | Global brain atrophy (HP:0002283) | 1.90078074 |
| 94 | Arterial thrombosis (HP:0004420) | 1.89779896 |
| 95 | Recurrent skin infections (HP:0001581) | 1.89726995 |
| 96 | Uterine leiomyosarcoma (HP:0002891) | 1.89357610 |
| 97 | Leiomyosarcoma (HP:0100243) | 1.89357610 |
| 98 | Abnormality of T cells (HP:0002843) | 1.88743407 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 1.88682917 |
| 100 | Blepharitis (HP:0000498) | 1.88285901 |
| 101 | Asymmetry of the thorax (HP:0001555) | 1.87854390 |
| 102 | Tetraparesis (HP:0002273) | 1.87543240 |
| 103 | Mediastinal lymphadenopathy (HP:0100721) | 1.86637598 |
| 104 | * Bladder carcinoma (HP:0002862) | 1.85899626 |
| 105 | * Bladder neoplasm (HP:0009725) | 1.85899626 |
| 106 | Stomatitis (HP:0010280) | 1.85665893 |
| 107 | Coarse hair (HP:0002208) | 1.85241663 |
| 108 | Increased IgE level (HP:0003212) | 1.84714473 |
| 109 | Cutis marmorata (HP:0000965) | 1.84676691 |
| 110 | Broad face (HP:0000283) | 1.84532031 |
| 111 | Scanning speech (HP:0002168) | 1.84268692 |
| 112 | Heterotopia (HP:0002282) | 1.83826729 |
| 113 | Arterial tortuosity (HP:0005116) | 1.82489867 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 1.81912733 |
| 115 | Vertebral arch anomaly (HP:0008438) | 1.80915824 |
| 116 | Periodontitis (HP:0000704) | 1.80752125 |
| 117 | Thick nail (HP:0001805) | 1.77825277 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.77727241 |
| 119 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77600149 |
| 120 | Obstructive lung disease (HP:0006536) | 1.77513520 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77513520 |
| 122 | Sepsis (HP:0100806) | 1.77367009 |
| 123 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.76768981 |
| 124 | Chronic otitis media (HP:0000389) | 1.76353065 |
| 125 | Keratoconjunctivitis (HP:0001096) | 1.76242762 |
| 126 | Inappropriate behavior (HP:0000719) | 1.75890253 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 1.75875261 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.75856580 |
| 129 | Cortical dysplasia (HP:0002539) | 1.74315265 |
| 130 | Chest pain (HP:0100749) | 1.74302960 |
| 131 | IgG deficiency (HP:0004315) | 1.73883640 |
| 132 | Cerebral aneurysm (HP:0004944) | 1.73393054 |
| 133 | Mucosal telangiectasiae (HP:0100579) | 1.71710924 |
| 134 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.69057872 |
| 135 | Abnormality of the lumbar spine (HP:0100712) | 1.68367932 |
| 136 | Cupped ribs (HP:0000887) | 1.67993434 |
| 137 | Gastrointestinal carcinoma (HP:0002672) | 1.67241439 |
| 138 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.67241439 |
| 139 | Porencephaly (HP:0002132) | 1.66643732 |
| 140 | Gingivitis (HP:0000230) | 1.66590040 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.66336844 |
| 142 | Vascular tortuosity (HP:0004948) | 1.66140538 |
| 143 | Long eyelashes (HP:0000527) | 1.65016355 |
| 144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63303790 |
| 145 | Mucopolysacchariduria (HP:0008155) | 1.63303790 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.62313361 |
| 147 | Thyroid carcinoma (HP:0002890) | 1.60743993 |
| 148 | Vertebral compression fractures (HP:0002953) | 1.60614540 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.60516658 |
| 150 | Flat acetabular roof (HP:0003180) | 1.60435675 |
| 151 | Myocardial infarction (HP:0001658) | 1.60376851 |
| 152 | Abnormal platelet volume (HP:0011876) | 1.59052927 |
| 153 | Hyperacusis (HP:0010780) | 1.58932153 |
| 154 | 11 pairs of ribs (HP:0000878) | 1.58792909 |
| 155 | Cerebral inclusion bodies (HP:0100314) | 1.57930327 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.56969819 |
| 157 | Lymphedema (HP:0001004) | 1.56776921 |
| 158 | Polycythemia (HP:0001901) | 1.56723279 |
| 159 | Menstrual irregularities (HP:0000858) | 1.56116311 |
| 160 | Diminished motivation (HP:0000745) | 1.55989539 |
| 161 | Relative macrocephaly (HP:0004482) | 1.55618930 |
| 162 | Slow saccadic eye movements (HP:0000514) | 1.55372705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.18289442 |
| 2 | MAP3K6 | 2.93472666 |
| 3 | EEF2K | 2.93309620 |
| 4 | SCYL2 | 2.74780491 |
| 5 | MAP4K1 | 2.72939104 |
| 6 | CAMK1D | 2.47939731 |
| 7 | CAMK1G | 2.42721923 |
| 8 | IRAK3 | 2.33363241 |
| 9 | TGFBR2 | 2.28569293 |
| 10 | BMPR2 | 2.18653852 |
| 11 | BLK | 2.17825231 |
| 12 | FGFR3 | 2.09317575 |
| 13 | CDK12 | 2.05431488 |
| 14 | STK10 | 2.04854508 |
| 15 | MAP3K10 | 2.04185174 |
| 16 | BRD4 | 1.80677539 |
| 17 | NUAK1 | 1.78451731 |
| 18 | TAOK3 | 1.73521066 |
| 19 | PDGFRA | 1.72531024 |
| 20 | DMPK | 1.69202267 |
| 21 | JAK1 | 1.65677909 |
| 22 | KSR2 | 1.61274185 |
| 23 | JAK3 | 1.60258572 |
| 24 | ITK | 1.60002510 |
| 25 | * CDK9 | 1.55605455 |
| 26 | TRIB3 | 1.55404062 |
| 27 | TYK2 | 1.55009224 |
| 28 | TXK | 1.52932831 |
| 29 | TTN | 1.51310704 |
| 30 | ICK | 1.47941020 |
| 31 | TRPM7 | 1.43179143 |
| 32 | EPHB1 | 1.42065230 |
| 33 | MAP3K4 | 1.40572247 |
| 34 | RIPK4 | 1.40436932 |
| 35 | FGR | 1.34275003 |
| 36 | STK4 | 1.33781575 |
| 37 | SMG1 | 1.33447695 |
| 38 | NEK9 | 1.32470417 |
| 39 | MAP3K2 | 1.31509932 |
| 40 | HIPK2 | 1.28468530 |
| 41 | * CDK6 | 1.25106498 |
| 42 | SYK | 1.23132362 |
| 43 | KSR1 | 1.23021142 |
| 44 | MAP3K14 | 1.22580708 |
| 45 | LATS1 | 1.21334409 |
| 46 | SGK3 | 1.16755184 |
| 47 | HCK | 1.12380222 |
| 48 | RET | 1.11811787 |
| 49 | STK3 | 1.10399820 |
| 50 | CDC7 | 1.09746113 |
| 51 | SIK2 | 1.08399980 |
| 52 | EPHA3 | 1.07725629 |
| 53 | IKBKE | 1.07306265 |
| 54 | TAOK1 | 1.06015640 |
| 55 | DYRK1B | 1.02571469 |
| 56 | GRK6 | 1.02100999 |
| 57 | RIPK1 | 1.01341610 |
| 58 | BTK | 1.01222152 |
| 59 | FGFR4 | 0.95683223 |
| 60 | YES1 | 0.95540120 |
| 61 | LRRK2 | 0.94860637 |
| 62 | DDR2 | 0.94575908 |
| 63 | JAK2 | 0.94506784 |
| 64 | KIT | 0.92940726 |
| 65 | ZAP70 | 0.92593728 |
| 66 | MELK | 0.92074039 |
| 67 | PKN2 | 0.91553426 |
| 68 | PIM1 | 0.91228569 |
| 69 | NLK | 0.90275201 |
| 70 | MAP2K7 | 0.89718255 |
| 71 | SIK3 | 0.89060463 |
| 72 | CAMKK2 | 0.88584965 |
| 73 | IRAK1 | 0.88385570 |
| 74 | LCK | 0.85791030 |
| 75 | MAP3K8 | 0.85059302 |
| 76 | MAP2K3 | 0.84867896 |
| 77 | MAP3K13 | 0.84626651 |
| 78 | MARK3 | 0.84273517 |
| 79 | SGK2 | 0.83459218 |
| 80 | CSF1R | 0.82651694 |
| 81 | TEC | 0.81874714 |
| 82 | MARK2 | 0.81831884 |
| 83 | CHUK | 0.80540959 |
| 84 | MAP3K1 | 0.80232500 |
| 85 | FGFR2 | 0.80149297 |
| 86 | LATS2 | 0.78609924 |
| 87 | RAF1 | 0.77857911 |
| 88 | IRAK2 | 0.76287658 |
| 89 | PRKAA2 | 0.75087149 |
| 90 | IRAK4 | 0.74392521 |
| 91 | RPS6KA4 | 0.73965967 |
| 92 | PDGFRB | 0.73768066 |
| 93 | MATK | 0.71825889 |
| 94 | MAP3K7 | 0.71685078 |
| 95 | NEK1 | 0.71399635 |
| 96 | MST4 | 0.71034957 |
| 97 | CDK7 | 0.70948696 |
| 98 | STK24 | 0.70860478 |
| 99 | PRKCQ | 0.70471570 |
| 100 | PTK6 | 0.68509180 |
| 101 | PRKCH | 0.68407830 |
| 102 | ERBB3 | 0.67405996 |
| 103 | MAPKAPK3 | 0.66197030 |
| 104 | EIF2AK1 | 0.65661432 |
| 105 | TNIK | 0.65117947 |
| 106 | CSNK1A1L | 0.64984594 |
| 107 | NTRK2 | 0.63674375 |
| 108 | TAOK2 | 0.63401929 |
| 109 | MAPKAPK2 | 0.62840453 |
| 110 | MKNK2 | 0.59022702 |
| 111 | SRPK1 | 0.58113180 |
| 112 | CDK8 | 0.58089939 |
| 113 | MAPK11 | 0.58039159 |
| 114 | IKBKB | 0.57889289 |
| 115 | CCNB1 | 0.57659099 |
| 116 | CSK | 0.56930700 |
| 117 | DYRK3 | 0.56669335 |
| 118 | WNK1 | 0.56538562 |
| 119 | WEE1 | 0.55727655 |
| 120 | STK11 | 0.55322428 |
| 121 | MOS | 0.54497501 |
| 122 | CDC42BPA | 0.54449682 |
| 123 | SIK1 | 0.53980286 |
| 124 | BRAF | 0.53933005 |
| 125 | MTOR | 0.53566302 |
| 126 | CLK1 | 0.52670295 |
| 127 | MAP3K3 | 0.52255687 |
| 128 | PAK4 | 0.51061272 |
| 129 | * ABL1 | 0.50843388 |
| 130 | LYN | 0.50825983 |
| 131 | MAPKAPK5 | 0.49932793 |
| 132 | PIK3CG | 0.49635312 |
| 133 | PRKD2 | 0.49345258 |
| 134 | MAP3K5 | 0.48822233 |
| 135 | MAPK7 | 0.46579756 |
| 136 | TBK1 | 0.46574255 |
| 137 | EGFR | 0.44145427 |
| 138 | * CDK14 | 0.43606595 |
| 139 | * CHEK1 | 0.43316472 |
| 140 | AKT2 | 0.41620592 |
| 141 | * CDK4 | 0.41510035 |
| 142 | SGK1 | 0.41150203 |
| 143 | FES | 0.40836422 |
| 144 | ERN1 | 0.40087386 |
| 145 | GRK7 | 0.39664086 |
| 146 | PDK1 | 0.39385879 |
| 147 | NEK6 | 0.37992471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.16526899 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02246058 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92118444 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75115588 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66349315 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64353854 |
| 7 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.61043661 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59381379 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58289917 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57360599 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51353836 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48197095 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46675822 |
| 14 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46281283 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45011607 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43847302 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.43795060 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.41638326 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38118849 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36969319 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31934155 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31333394 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.28308495 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24715083 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.21643522 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.20847046 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.17187282 |
| 28 | * Hepatitis B_Homo sapiens_hsa05161 | 1.16628008 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16566424 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.16457412 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15684832 |
| 32 | * Bladder cancer_Homo sapiens_hsa05219 | 1.13786829 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.13609083 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13211575 |
| 35 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.13006593 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12789088 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09881206 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08388360 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08323620 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07102780 |
| 41 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.07061718 |
| 42 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06316046 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06314381 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06215204 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.05933283 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05812741 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05132491 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.05112692 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04391218 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03479290 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01660567 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.99046915 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98754259 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.94976098 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.94811623 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.94729699 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94150437 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93666786 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92185761 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.91816800 |
| 61 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.91625324 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90333847 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89881022 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88573256 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88261188 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87779299 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87177458 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87126808 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86451133 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.86361558 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85219117 |
| 72 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.84973633 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.84565082 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84145034 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.84136780 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83827011 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.82870486 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82192242 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81566612 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81392797 |
| 81 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80803036 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.80558967 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80178675 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.79477080 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77901763 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77759432 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.77376219 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76707377 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76640095 |
| 90 | * Glioma_Homo sapiens_hsa05214 | 0.76577808 |
| 91 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74959998 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.74702365 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74032787 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.73910330 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.73097204 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72346578 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71768944 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71337625 |
| 99 | * Prostate cancer_Homo sapiens_hsa05215 | 0.71207214 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71003185 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69760217 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69543210 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69242791 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69065558 |
| 105 | DNA replication_Homo sapiens_hsa03030 | 0.67868540 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67413482 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66249891 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65735720 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64918217 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64672829 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63727522 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.63216738 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.63090348 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.62302711 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60246505 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59951441 |
| 117 | * Cell cycle_Homo sapiens_hsa04110 | 0.59392306 |
| 118 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.58788290 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.58586356 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58198828 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56600997 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56003667 |

